The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Modelling EuroQol health‐related utility values for diabetic complications from CODE‐2 data
Open accessAbstract
Recent research has employed different analytical techniques to estimate the impact of the various long‐term complications of type 2 diabetes on health‐related utility and health status. However, limited patient numbers or lack of variety of patient experience has limited their power to discriminate between separate complications and grades of severity. In this study alternative statistical model forms were compared to investigate the influence of various factors on self‐assessed health status and calculated utility scores, including the presence and severity of complications, and type of diabetes therapy. Responses to the EuroQol EQ‐5D questionnaire from 4641 patients with type 2 diabetes in 5 European countries were analysed. Simple multiple regression analysis was used to model both visual analogue scale (VAS) scores and time trade‐off index scores (TTO). Also, two complex models were developed for TTO analysis using a structure suggested by the EuroQol calculation algorithm. Both VAS and TTO models achieved greater explanatory power than in earlier studies. Relative weightings for individual complications differed between VAS and TTO scales, reflecting the strong influence of loss of mobility and severe pain in the EuroQol algorithm. Insulin‐based therapy was uniformly associated with a detrimental effect equivalent to an additional moderate complication. Evidence was found that TTO values are not responsive in cases where 3 or more multiple complications are present, and therefore may underestimate utility loss for patients most adversely affected by complex chronic diseases like diabetes. Copyright © 2004 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A social tariff for EuroQol: results from a UK general population surveyPreprint
Dolan, P., Gudex, C. M., Kind, P., & Williams, A. (1995) · RePEc: Research Papers in Economics · Cited by 611
Health-Related Quality of Life and Treatment Satisfaction in Dutch Patients With Type 2 Diabetes
Redekop, W. K., Koopmanschap, M. A., Stolk, R. P., Rutten, G. E. H. M., Wolffenbuttel, B. H. R., & Niessen, L. W. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.458 · Cited by 565
Estimating Utility Values for Health States of Type 2 Diabetic Patients Using the EQ-5D (UKPDS 62)
Clarke, P., Gray, A., & Holman, R. (2002) · Medical Decision Making · doi:10.1177/027298902400448902 · Cited by 515
The Evaluation of Two Measures of Quality of Life in Patients With Type I and Type II Diabetes
Jacobson, A. M., Groot, M. D., & Samson, J. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.4.267 · Cited by 508
Quality of Life and Associated Characteristics in a Large National Sample of Adults With Diabetes
Glasgow, R. E., Ruggiero, L., Eakin, E. G., Dryfoos, J., & Chobanian, L. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.562 · Cited by 471
Testa, M. A., & Simonson, D. C. (1998) · JAMA · doi:10.1001/jama.280.17.1490 · Cited by 418
Badia, X., Roset, M., Herdman, M., & Kind, P. (2001) · Medical Decision Making · doi:10.1177/0272989x0102100102 · Cited by 338
Lloyd, A., Sawyer, W., & Hopkinson, P. (2001) · Value in Health · doi:10.1046/j.1524-4733.2001.45029.x · Cited by 229
The Cost of Diabetes Type II in Europe The CODE-2 Study
Massi‐Benedetti, M. (2002) · Diabetologia · doi:10.1007/s00125-002-0860-3 · Cited by 202
Coping with Type II diabetes: the patient’s perspective
Koopmanschap, M. (2002) · Diabetologia · doi:10.1007/s00125-002-0861-2 · Cited by 158
An economic model of the long-term health care burden of Type II diabetes
Bagust, A., Hopkinson, P. K., Maier, W., & Currie, C. J. (2001) · Diabetologia · doi:10.1007/s001250100023 · Cited by 128
Self-citationQuality of life in NIDDM patients assessed with the SF-20 questionnaire
Hänninen, J., Takala, J. K., & Keinanen-Kiukaanniemi, S. M. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00085-0 · Cited by 100
Determinants of the quality of life of patients with diabetes under intensified insulin therapy.
Rose, M., Burkert, U., Scholler, G., Schirop, T., Danzer, G., & Klapp, B. F. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1876 · Cited by 65
Relationship of Health-Related Quality of Life to Symptom Severity in Diabetes Mellitus
Gulliford, M. C., & Mahabir, D. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00053-0 · Cited by 57
Cited by
Review of Utility Values for Economic Modeling in Type 2 Diabetes
Beaudet, A., Clegg, J., Thuresson, P.-O., Lloyd, A., & McEwan, P. (2014) · Value in Health · doi:10.1016/j.jval.2014.03.003 · Cited by 256
Fenwick, E. K., Xie, J., Ratcliffe, J., Pesudovs, K., Finger, R. P., Wong, T. Y., & Lamoureux, E. L. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8992 · Cited by 101
Choi, J. G., Winn, A. N., Skandari, M. R., Franco, M. I., Staab, E. M., Alexander, J., Wan, W., Zhu, M., Huang, E. S., Philipson, L., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m21-2941 · Cited by 87
Health utility values associated with diabetic retinopathy
Lloyd, A., Nafees, B., Gavriel, S., Rousculp, M. D., Boye, K. S., & Ahmad, A. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02430.x · Cited by 83
Cai, X., Shi, L., Yang, W., Gu, S., Chen, Y., Nie, L., & Ji, L. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1570220 · Cited by 37
Metadata
- Authors
- Bagust, A., & Beale, S.
- Venue
- Health Economics
- Publisher
- Wiley
- Published
- 2004-09-07
- Volume
- 14
- Issue
- 3
- Pages
- 217-230
- ISSN
- 1057-9230 (ISSN-L)
- 1099-1050
- OpenAlex
- W2118472474
- Cited by
- 260
- References
- 15
- FWCI
- 20.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.